Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
...nts the trials findings June 4, 2007 at the annual meeting of the American Society of Clinical Oncology in Chicago. The results of the 65-site trial also showed that those patients who underwent chemotherapy and whose CTC number went down fared better and had a more favorable prognosis. That is, the level of...Research shows survival benefit for leukemia patients treated with arsenic trioxide
...Center, presented the findings today at the annual meeting of the American Society of Clinical Oncology (ASCO). Nearly 600 patients in the U.S. and Canada participated in the phase III study over a six-year period from June 1999 through March 2005. The study was sponsored by the National Cancer Institute...U-M study finds lymphoma drug effective over long term
...t the American Society of Clinical Oncology annual meeting in Chicago. "These results compare quite favorably with those achieved with state-of-the-art chemotherapy regimens that take months to deliver. But Bexxar is given as a single treatment, completed within one week, which makes it an extremely conven...Gender impacts colorectal cancer progression
...udy were displayed on Monday, June 4 at the annual meeting of the American Society of Clinical Oncology (ASCO) held at McCormick Place in Chicago. The study focused specifically on patients who had been treated with 5-Fluorouracil and oxaliplatin chemotherapy, Lenz says. Researchers were able to identify ...African-American men understimate risk of prostate cancer
...t the American Society of Clinical Oncology annual meeting in Chicago, say this is alarming. African-American men have a higher incidence rate, are diagnosed later, and have a higher mortality rate from prostate cancer than Caucasians. "A group that underestimates the risk of having cancer is likely to u...Hot flashes may be welcome sign in women with breast cancer, study says
...merican Society of Clinical Oncology (ASCO) annual meeting in Chicago today. "Hot flashes are a very common and disruptive problem in breast cancer survivors," said the study's first author Joanne Mortimer, M.D. , medical director of the Moores Cancer Center and professor of medicine with the UCSD Sch...Revlimid data presented at ASCO stands to change the way physicians treat multiple myeloma
...t the American Society of Clinical Oncology (ASCO) meeting in Chicago and demonstrate the benefits of using Revlimid (lenalidomide) with reduced doses of the steroid dexamethasone. Based upon these data, the U.S. Myeloma Forum, a committee of leading myeloma researchers including Dr. Mohamad Hussein, Clinic...Drug shows activity against brain metastases
...a-Farber Cancer Institute scientists at the annual meeting of the American Society of Clinical Oncology. Researchers said the drug, also known as Tykerb, should undergo further testing in combination with other drugs as a treatment for breast cancer that has spread to the brain. Results of this study ind...Even when child's cancer prognosis is poor, parent/physician communication can provide hope
...t the American Society of Clinical Oncology annual meeting on Sunday, June 3, at 7:30 a.m. CDT. Previous studies suggest that physicians are reluctant to give prognostic information, out of fear that it will destroy hope, said Jennifer Mack, MD, the studys lead author. Strikingly, we found that honest comm...Herceptin does not increase heart failure in patients long term
...roject (NSABP) trial B-31, presented at the annual meeting of the American Society of Clinical Oncology (ASCO...ounced at the Womens Cancers press briefing at the meeting and published in Abstract LBA513 in the ASCO proceedings. The information we obtained from this ...Brain-boosting pill alleviates post-chemotherapy fogginess
...une 3 at the American Society of Clinical Oncology meeting in Chicago. ASCO is honoring Kohli with a Merit Award. Originally licensed to treat narcolepsy, modafinil promotes wakefulness and seems to boost brainpower without causing the jittery, restless feelings induced by amphetamines. Modafinil is part o...Adding radioimmunotherapy to chemo may help patients with lymphoma
...edical Center (UPMC) study presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago and published as Abstract 8005 in the ASCO proceedings. Over 90 percent of study patients responded completely to the treatment and since only a short-course of chemotherapy was used, s...Treatment for early prostate cancer associated with type of specialist seen
... treatments." The study, presented at the annual meeting of the American Society of Clinical Oncologists, reviewed the records of 85,088 men aged 65 and older who were diagnosed with prostate cancer between 1994 and 2002 using information from the SEER (Surveillance, Epidemiology, and End Results) Medicare...Nonhormonal drug reduces hot flashes in men treated for prostate cancer
...rolled Phase III clinical trial at the 2007 annual meeting of the American Society of Clinical Oncology ( http://www.asco.org/portal/site/ASCO ), Mayo Clinic investigators report that the drug gabapentin reduced the frequency and the intensity of hot flashes by up to 46 percent in men receiving androgen depr...Genetic mutations identified for type of gastric cancer
...ly to coincide with its presentation at the annual meeting of the American Society of Clinical Oncology. According to background information in the article, gastric cancer is the second most common cause of cancer death worldwide. There are two major variants of this cancer: an intestinal type and a diffus...Tumor cell activity may provide clues for treating breast cancer in young women
...t the American Society of Clinical Oncology annual meeting in Chicago. The study was funded by the National Institutes of Health. During the process by which cells change and become cancerous, we saw certain patterns in young womens tumors that we didnt see in the tumors found in women over the age of 45, ...Antidepressant does not improve symptoms in advanced cancer patients without major depression
...paper at the American Society of Clinical Oncology meeting in Chicago and in the July edition of The Lancet Oncology. Self-ratings of depression, mood, fatigue, and quality of life are significant predictors of survival in patients with advanced cancer. Although the simple explanation for this is that peo...Exercise lowers insulin in breast cancer survivors
... Cancer Institute in Boston reported at the annual meeting of the American Society of Clinical Oncology in Chicago. Although it was previously demonstrated that women who lost weight and became more active could lower their risk of breast cancer recurrence, scientists couldnt explain how it worked. Jenni...E/Tablet technology may provide benefits to patients, researchers
...t the American Society of Clinical Oncology annual meeting in Chicago. The study was funded by Pfizer Inc. ...tion for clinical trials. Results presented at the meeting demonstrate that E/Tablets are just as reliable as paper forms for collecting the type of data neede...Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
...paper at the American Society of Clinical Oncology meeting in Chicago. And an accompanying comment says that surgery should not be delayed through using neo-adjuvant chemotherapy; it recommends that chemotherapy should take place after surgery (adjuvant chemotherapy). Richard Stephens, Medical Research C...